News & Updates

How to optimize treatment strategies for mHSPC by integrating pivotal data?

Theranostics in prostate cancer management: Current strategies and real-world data

Earlier use of lutetium-177 (¹⁷⁷Lu) prostate-specific membrane antigen (PSMA)–radioligand therapy (RLT) in combination with chemotherapy is shaping the future of prostate cancer management, according to Dr Yu-Yi Huang of the Department of Nuclear Medicine, Koo-Foundation Sun Yat-Sen Cancer Center (SYSCC), Taiwan, at Uro-Oncology Asia 2025.

Tislelizumab plus nab-paclitaxel shows therapeutic potential against bladder cancer

Treatment with the combination of the immune checkpoint inhibitor tislelizumab plus low-dose nab-paclitaxel exerts promising antitumour activity in patients with very high risk non–muscle-invasive bladder cancer who are ineligible for or decline radical cystectomy, according to the results of the phase II TRUCE-02 trial.

Social vulnerability implicated in urinary incontinence burden in women

Women who are socially vulnerable appear to have worse urinary incontinence and poorer incontinence-related quality of life, according to a study.

Ureteral stent omission safe, feasible in RARC-IC

A recent study has shown the safety and feasibility of omitting ureteral stent placement during robot-assisted radical cystectomy with intracorporeal ileal conduit (RARC-IC).

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

Using tranexamic acid (TXA) appears to lessen blood loss and the need for perioperative blood transfusion (PBT) without increasing the risk of venous thromboembolism (VTE) in patients with bladder cancer undergoing radical cystectomy, reports a study.

Original New Drug Application Approvals by US FDA (16-28 February 2025)

New drug applications approved by US FDA as of 16-28 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Impulse control tied to ejaculation time in men with PE

Impulse control appears to be associated with ejaculation time in men with premature ejaculation (PE), suggest the results of a cross-sectional observational study.

Remnant cholesterol linked to low testosterone in men

A close association exists between remnant cholesterol (RC) and the risk of low testosterone levels in adult men, suggests a nationwide study.